The report provides value (USD million) data for all the industry categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides industry player shares and distribution shares data for each of the aforementioned industry categories. The report is supplemented with global corporate-level profiles of the key industry participants.


Scope of the Research

- Countries covered include France, Germany, Italy, Spain and United Kingdom.
- Industry size and market share data for Drug Delivery Devices industry categories – Central Venous Catheters, Infusion Systems,Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized industry revenues (USD million) data for each of the industry categories in each of the country. Data from 2003 to 2010, projection forward for 7 years to 2017.
- 2010 industry player shares and distribution shares data for each of the industry categories and countries.
- Global corporate-level profiles of key industry players operating within the Europe Drug Delivery Devices industry ..
- Key Companies covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca PLC, Sunovion, B. Braun Melsungen AG, Baxter International Inc. and others.

Reasons to buy

- Develop innovative strategies by selecting the key market segment expected to grow .
- Develop successful market-entry strategies .
- Understand and respond to your competition by identifying who-stands-where in the Europe Drug Delivery Devices competitive landscape.
- Facilitate better investment decision making by identifying the key industry sectors expected to register strong growth in the near future.
- What are the best distribution channels and what’s the most preferred mode of product distribution – Identify, understand and decide.

Table Of Contents

1 Table of Contents

I Table of Contents 2
I. 1 List of Data tables 8
I. 2 List of Charts 11

II Introduction 13
II. 1 About this Report and the Author 13

III Drug Delivery Devices in Europe 14
III. 1 Drug Delivery Devices Cross Country Comparison, Sales (USD Million), from 2003 to 2017 14
III. 2 Drug Delivery Devices, Europe, Overall Sales (USD Million), from 2003 to 2017 15
III. 3 Drug Delivery Devices, Europe, Segment Volume (Units), from 2003 to 2017 22
III. 4 Drug Delivery Devices, Europe, Firms share (2009-2010) 27

IV Drug Delivery Devices In Germany 29
IV. 1 Drug Delivery Devices, Germany, Overall Sales (USD Million), from 2003 to 2017 29
IV. 2 Drug Delivery Devices, Germany, Segment Volume (Units), from 2003 to 2017 35
IV. 3 Drug Delivery Devices, Germany, Distribution Channel (2009-2010) 40
IV. 3.1 Central Venous Catheters, Germany, Distribution Channel (2009-2010) 40
IV. 3.2 Infusion Systems, Germany, Distribution Channel (2009-2010) 40
IV. 3.3 Metered Dose Inhaler Devices, Germany, Distribution Channel (2009-2010) 41
IV. 3.4 Needle Free Injections, Germany, Distribution Channel (2009-2010) 41
IV. 4 Drug Delivery Devices, Germany, Market Shares (2009-2010) 42
IV. 4.1 Drug Delivery Devices, Germany, Market Shares (2009-2010) 42
IV. 4.2 Central Venous Catheters, Germany, Market Shares (2009-2010) 44
IV. 4.3 Infusion Systems, Germany, Market Shares (2009-2010) 46
IV. 4.4 Metered Dose Inhaler Devices, Germany, Market Shares (2009-2010) 48
IV. 4.5 Needle Free Injections, Germany, Market Shares (2009-2010) 50

V Drug Delivery Devices In France 51
V. 1 Drug Delivery Devices, France, Overall Sales (USD Million), from 2003 to 2017 51
V. 2 Drug Delivery Devices, France, Segment Volume (Units), from 2003 to 2017 57
V. 3 Drug Delivery Devices, France, Distribution Channel (2009-2010) 62
V. 3.1 Central Venous Catheters, France, Distribution Channel (2009-2010) 62
V. 3.2 Infusion Systems, France, Distribution Channel (2009-2010) 62
V. 3.3 Metered Dose Inhaler Devices, France, Distribution Channel (2009-2010) 63
V. 3.4 Needle Free Injections, France, Distribution Channel (2009-2010) 63
V. 4 Drug Delivery Devices, France, Market Shares (2009-2010) 64
V. 4.1 Drug Delivery Devices, France, Market Shares (2009-2010) 64
V. 4.2 Central Venous Catheters, France, Market Shares (2009-2010) 66
V. 4.3 Infusion Systems, France, Market Shares (2009-2010) 68
V. 4.4 Metered Dose Inhaler Devices, France, Market Shares (2009-2010) 70
V. 4.5 Needle Free Injections, France, Market Shares (2009-2010) 71

VI Drug Delivery Devices In United Kingdom 72
VI. 1 Drug Delivery Devices, United Kingdom, Overall Sales (USD Million), from 2003 to 2017 72
VI. 2 Drug Delivery Devices, United Kingdom, Segment Volume (Units), from 2003 to 2017 78
VI. 3 Drug Delivery Devices, United Kingdom, Distribution Channel (2009-2010) 83
VI. 3.1 Central Venous Catheters, United Kingdom, Distribution Channel (2009-2010) 83
VI. 3.2 Infusion Systems, United Kingdom, Distribution Channel (2009-2010) 83
VI. 3.3 Metered Dose Inhaler Devices, United Kingdom, Distribution Channel (2009-2010) 84
VI. 3.4 Needle Free Injections, United Kingdom, Distribution Channel (2009-2010) 84
VI. 4 Drug Delivery Devices, United Kingdom, Market Shares (2009-2010) 85
VI. 4.1 Drug Delivery Devices, United Kingdom, Market Shares (2009-2010) 85
VI. 4.2 Central Venous Catheters, United Kingdom, Market Shares (2009-2010) 87
VI. 4.3 Infusion Systems, United Kingdom, Market Shares (2009-2010) 89
VI. 4.4 Metered Dose Inhaler Devices, United Kingdom, Market Shares (2009-2010) 91
VI. 4.5 Needle Free Injections, United Kingdom, Market Shares (2009-2010) 92

VII Drug Delivery Devices In Italy 93
VII. 1 Drug Delivery Devices, Italy, Overall Sales (USD Million), from 2003 to 2017 93
VII. 2 Drug Delivery Devices, Italy, Segment Volume (Units), from 2003 to 2017 99
VII. 3 Drug Delivery Devices, Italy, Distribution Channel (2009-2010) 104
VII. 3.1 Central Venous Catheters, Italy, Distribution Channel (2009-2010) 104
VII. 3.2 Infusion Systems, Italy, Distribution Channel (2009-2010) 104
VII. 3.3 Metered Dose Inhaler Devices, Italy, Distribution Channel (2009-2010) 105
VII. 3.4 Needle Free Injections, Italy, Distribution Channel (2009-2010) 105
VII. 4 Drug Delivery Devices, Italy, Market Shares (2009-2010) 106
VII. 4.1 Drug Delivery Devices, Italy, Market Shares (2009-2010) 106
VII. 4.2 Central Venous Catheters, Italy, Market Shares (2009-2010) 108
VII. 4.3 Infusion Systems, Italy, Market Shares (2009-2010) 110
VII. 4.4 Metered Dose Inhaler Devices, Italy, Market Shares (2009-2010) 112
VII. 4.5 Needle Free Injections, Italy, Market Shares (2009-2010) 114

VIII Drug Delivery Devices In Spain 115
VIII. 1 Drug Delivery Devices, Spain, Overall Sales (USD Million), from 2003 to 2017 115
VIII. 2 Drug Delivery Devices, Spain, Segment Volume (Units), from 2003 to 2017 121
VIII. 3 Hospital Supplies, Spain, Distribution Channel (2009-2010) 126
VIII. 3.1 Central Venous Catheters, Spain, Distribution Channel (2009-2010) 126
VIII. 3.2 Infusion Systems, Spain, Distribution Channel (2009-2010) 126
VIII. 3.3 Metered Dose Inhaler Devices, Spain, Distribution Channel (2009-2010) 127
VIII. 3.4 Needle Free Injections, Spain, Distribution Channel (2009-2010) 127
VIII. 4 Drug Delivery Devices, Spain, Market Shares (2009-2010) 128
VIII. 4.1 Drug Delivery Devices, Spain, Market Shares (2009-2010) 128
VIII. 4.2 Central Venous Catheters, Spain, Market Shares (2009-2010) 130
VIII. 4.3 Infusion Systems, Spain, Market Shares (2009-2010) 132
VIII. 4.4 Metered Dose Inhaler Devices, Spain, Market Shares (2009-2010) 134
VIII. 4.5 Needle Free Injections, Spain, Market Shares (2009-2010) 135

IX Overview of Key Firms in Europe Drug Delivery Devices March ket 136
IX. 1 GlaxoSmithKline plc 136
IX. 1.1 Company Profile 136
IX. 1.2 Share in the Europe Drug Delivery Devices March ket 136
IX. 2 Boehringer Ingelheim GmbH 137
IX. 2.1 Company Profile 137
IX. 2.2 Share in the Europe Drug Delivery Devices March ket 137
IX. 3 AstraZeneca PLC 138
IX. 3.1 Company Profile 138
IX. 3.2 Share in the Europe Drug Delivery Devices March ket 138
IX. 4 Sunovion 139
IX. 4.1 Share in the Europe Drug Delivery Devices March ket 139
IX. 5 Baxter International Inc. 140
IX. 5.1 Company Profile 140
IX. 5.2 Share in the Europe Drug Delivery Devices March ket 140
IX. 6 B. Braun Melsungen AG 141
IX. 6.1 Company Profile 141
IX. 6.2 Share in the Europe Drug Delivery Devices March ket 141
IX. 7 CareFusion Corporation 142
IX. 7.1 Company Profile 142
IX. 8 Fresenius Kabi AG 142
IX. 8.1 Company Profile 142
IX. 9 Hospira, Inc. 142
IX. 9.1 Company Profile 142
IX. 10 Medtronic, Inc. 143
IX. 10.1 Company Profile 143
IX. 11 Smiths Medical 143
IX. 11.1 Company Profile 143
IX. 12 Terumo Corporation 143
IX. 12.1 Company Profile 143
IX. 13 Consort Medical plc 144
IX. 13.1 Company Profile 144
IX. 14 3M Health Care 144
IX. 14.1 Company Profile 144
IX. 15 Codman and Shurtleff, Inc. 144
IX. 15.1 Company Profile 144
IX. 16 JMS CO., LTD. 145
IX. 16.1 Company Profile 145
IX. 17 Teleflex Incorporated 145
IX. 17.1 Company Profile 145
IX. 18 Edwards Lifesciences Corporation 146
IX. 18.1 Company Profile 146
IX. 19 Cook Medical Incorporated 146
IX. 19.1 Company Profile 146
IX. 20 INJEX - Equidyne Systems 146
IX. 20.1 Company Profile 146
IX. 21 Bioject Medical Technologies Inc. 147
IX. 21.1 Company Profile 147
IX. 22 Antares Pharma, Inc. 147
IX. 22.1 Company Profile 147

X Drug Delivery Devices March ket Pipeline Products 148

XI Financial Deals Landscape 152
XI. 1 Acquisition 152
XI. 1.1 Runfold Medical Takes Over Zimed 152
XI. 2 Partner agreements 153
XI. 2.1 AorTech International Enters Into Technology License Agreement 153

XII Recent Developments 154
XII. 1 Company Vision and Strategy 154
XII. 1.1 August 19, 2010: Archimedes Pharma Announces New US Headquarters In Bedminster, New Jersey 154
XII. 1.2 July 27, 2010: GE Healthcare Opens New US$ 15 Mln Life Sciences Manufacturing Center In Wales, UK 154
XII. 1.3 July 13, 2010: GE Healthcare Opens New Medical Technology Manufacturing Facility In Cardiff, UK 154
XII. 2 Legal and Regulatory 155
XII. 2.1 January 17, 2011: GlaxoSmithKline Announces Q4 2010 Legal Charge 155

XIII Appendix 156
XIII. 1 Definitions of March kets Covered in the Report 157
XIII. 1.1 Drug Delivery Devices 157
XIII. 2 Research Methodology 158
XIII. 3 Secondary Research 158
XIII. 4 Primary Research 159
XIII. 5 Models 159
XIII. 6 Forecasted data s 160
XIII. 7 Expert Panels 160
XIII. 8 GlobalData Consulting 160
XIII. 9 Currency Conversion 161
XIII. 10 Contact Us 161
XIII. 11 Disclaimer 161

1.1

List of Tables


Data table 1: Drug Delivery Devices, Cross Country Comparison, Sales (USD Million), from 2003 to 2017 14
Data table 2: Drug Delivery Devices, Europe, Overall Sales (USD Million), from 2003 to 2017 16
Data table 3: Drug Delivery Devices, Europe, Cross-Category Analysis, from 2003 to 2017 17
Data table 4: Drug Delivery Devices, Europe, Overall Sales (USD Million), Historical data, from 2003 to 2010 19
Data table 5: Drug Delivery Devices, Europe, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 21
Data table 6: Drug Delivery Devices, Europe, Segment Volume (Units), from 2003 to 2017 22
Data table 7: Drug Delivery Devices, Europe, Segment Volume (Units), Historical data, from 2003 to 2010 24
Data table 8: Drug Delivery Devices, Europe, Segment Volume (Units), Forecasted data, from 2010 to 2017 26
Data table 9: Drug Delivery Devices, Europe, Firms share by Sales (USD Million), from 2009 to 2010 28
Data table 10: Drug Delivery Devices, Germany, Overall Sales (USD Million), from 2003 to 2017 30
Data table 11: Drug Delivery Devices, Germany, Overall Sales (USD Million), Historical data, from 2003 to 2010 32
Data table 12: Drug Delivery Devices, Germany, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 34
Data table 13: Drug Delivery Devices, Germany, Segment Volume (Units), from 2003 to 2017 35
Data table 14: Drug Delivery Devices, Germany, Segment Volume (Units), Historical data, from 2003 to 2010 37
Data table 15: Drug Delivery Devices, Germany, Segment Volume (Units), Forecasted data, from 2010 to 2017 39
Data table 16: Central Venous Catheters, Germany, Distribution Channel by Sales (USD Million), from 2009 to 2010 40
Data table 17: Infusion Systems, Germany, Distribution Channel by Sales (USD Million), from 2009 to 2010 40
Data table 18: Metered Dose Inhaler Devices, Germany, Distribution Channel by Sales (USD Million), from 2009 to 2010 41
Data table 19: Needle Free Injections, Germany, Distribution Channel by Sales (USD Million), from 2009 to 2010 41
Data table 20: Drug Delivery Devices, Germany, Market Shares by Sales (USD Million), from 2009 to 2010 43
Data table 21: Central Venous Catheters, Germany, Market Shares by Sales (USD Million), from 2009 to 2010 45
Data table 22: Infusion Systems, Germany, Market Shares by Sales (USD Million), from 2009 to 2010 47
Data table 23: Metered Dose Inhaler Devices, Germany, Market Shares by Sales (USD Million), from 2009 to 2010 49
Data table 24: Needle Free Injections, Germany, Market Shares by Sales (USD Million), from 2009 to 2010 50
Data table 25: Drug Delivery Devices, France, Overall Sales (USD Million), from 2003 to 2017 52
Data table 26: Drug Delivery Devices, France, Overall Sales (USD Million), Historical data, from 2003 to 2010 54
Data table 27: Drug Delivery Devices, France, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 56
Data table 28: Drug Delivery Devices, France, Segment Volume (Units), from 2003 to 2017 57
Data table 29: Drug Delivery Devices, France, Segment Volume (Units), Historical data, from 2003 to 2010 59
Data table 30: Drug Delivery Devices, France, Segment Volume (Units), Forecasted data, from 2010 to 2017 61
Data table 31: Central Venous Catheters, France, Distribution Channel by Sales (USD Million), from 2009 to 2010 62
Data table 32: Infusion Systems, France, Distribution Channel by Sales (USD Million), from 2009 to 2010 62
Data table 33: Metered Dose Inhaler Devices, France, Distribution Channel by Sales (USD Million), from 2009 to 2010 63
Data table 34: Needle Free Injections, France, Distribution Channel by Sales (USD Million), from 2009 to 2010 63
Data table 35: Drug Delivery Devices, France, Market Shares by Sales (USD Million), from 2009 to 2010 65
Data table 36: Central Venous Catheters, France, Market Shares by Sales (USD Million), from 2009 to 2010 67
Data table 37: Infusion Systems, France, Market Shares by Sales (USD Million), from 2009 to 2010 69
Data table 38: Metered Dose Inhaler Devices, France, Market Shares by Sales (USD Million), from 2009 to 2010 70
Data table 39: Needle Free Injections, France, Market Shares by Sales (USD Million), from 2009 to 2010 71
Data table 40: Drug Delivery Devices, United Kingdom, Overall Sales (USD Million), from 2003 to 2017 73
Data table 41: Drug Delivery Devices, United Kingdom, Overall Sales (USD Million), Historical data, from 2003 to 2010 75
Data table 42: Drug Delivery Devices, United Kingdom, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 77
Data table 43: Drug Delivery Devices, United Kingdom, Segment Volume (Units), from 2003 to 2017 78
Data table 44: Drug Delivery Devices, United Kingdom, Segment Volume (Units), Historical data, from 2003 to 2010 80
Data table 45: Drug Delivery Devices, United Kingdom, Segment Volume (Units), Forecasted data, from 2010 to 2017 82
Data table 46: Central Venous Catheters, United Kingdom, Distribution Channel by Sales (USD Million), from 2009 to 2010 83
Data table 47: Infusion Systems, United Kingdom, Distribution Channel by Sales (USD Million), from 2009 to 2010 83
Data table 48: Metered Dose Inhaler Devices, United Kingdom, Distribution Channel by Sales (USD Million), from 2009 to 2010 84
Data table 49: Needle Free Injections, United Kingdom, Distribution Channel by Sales (USD Million), from 2009 to 2010 84
Data table 50: Drug Delivery Devices, United Kingdom, Market Shares by Sales (USD Million), from 2009 to 2010 86
Data table 51: Central Venous Catheters, United Kingdom, Market Shares by Sales (USD Million), from 2009 to 2010 88
Data table 52: Infusion Systems, United Kingdom, Market Shares by Sales (USD Million), from 2009 to 2010 90
Data table 53: Metered Dose Inhaler Devices, United Kingdom, Market Shares by Sales (USD Million), from 2009 to 2010 91
Data table 54: Needle Free Injections, United Kingdom, Market Shares by Sales (USD Million), from 2009 to 2010 92
Data table 55: Drug Delivery Devices, Italy, Overall Sales (USD Million), from 2003 to 2017 94
Data table 56: Drug Delivery Devices, Italy, Overall Sales (USD Million), Historical data, from 2003 to 2010 96
Data table 57: Drug Delivery Devices, Italy, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 98
Data table 58: Drug Delivery Devices, Italy, Segment Volume (Units), from 2003 to 2017 99
Data table 59: Drug Delivery Devices, Italy, Segment Volume (Units), Historical data, from 2003 to 2010 101
Data table 60: Drug Delivery Devices, Italy, Segment Volume (Units), Forecasted data, from 2010 to 2017 103
Data table 61: Central Venous Catheters, Italy, Distribution Channel by Sales (USD Million), from 2009 to 2010 104
Data table 62: Infusion Systems, Italy, Distribution Channel by Sales (USD Million), from 2009 to 2010 104
Data table 63: Metered Dose Inhaler Devices, Italy, Distribution Channel by Sales (USD Million), from 2009 to 2010 105
Data table 64: Needle Free Injections, Italy, Distribution Channel by Sales (USD Million), from 2009 to 2010 105
Data table 65: Drug Delivery Devices, Italy, Market Shares by Sales (USD Million), from 2009 to 2010 107
Data table 66: Central Venous Catheters, Italy, Market Shares by Sales (USD Million), from 2009 to 2010 109
Data table 67: Infusion Systems, Italy, Market Shares by Sales (USD Million), from 2009 to 2010 111
Data table 68: Metered Dose Inhaler Devices, Italy, Market Shares by Sales (USD Million), from 2009 to 2010 113
Data table 69: Needle Free Injections, Italy, Market Shares by Sales (USD Million), from 2009 to 2010 114
Data table 70: Drug Delivery Devices, Spain, Overall Sales (USD Million), from 2003 to 2017 116
Data table 71: Drug Delivery Devices, Spain, Overall Sales (USD Million), Historical data, from 2003 to 2010 118
Data table 72: Drug Delivery Devices, Spain, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 120
Data table 73: Drug Delivery Devices, Spain, Segment Volume (Units), from 2003 to 2017 121
Data table 74: Drug Delivery Devices, Spain, Segment Volume (Units), Historical data, from 2003 to 2010 123
Data table 75: Drug Delivery Devices, Spain, Segment Volume (Units), Forecasted data, from 2010 to 2017 125
Data table 76: Central Venous Catheters, Spain, Distribution Channel by Sales (USD Million), from 2009 to 2010 126
Data table 77: Infusion Systems, Spain, Distribution Channel by Sales (USD Million), from 2009 to 2010 126
Data table 78: Metered Dose Inhaler Devices, Spain, Distribution Channel by Sales (USD Million), from 2009 to 2010 127
Data table 79: Needle Free Injections, Spain, Distribution Channel by Sales (USD Million), from 2009 to 2010 127
Data table 80: Drug Delivery Devices, Spain, Market Shares by Sales (USD Million), from 2009 to 2010 129
Data table 81: Central Venous Catheters, Spain, Market Shares by Sales (USD Million), from 2009 to 2010 131
Data table 82: Infusion Systems, Spain, Market Shares by Sales (USD Million), from 2009 to 2010 133
Data table 83: Metered Dose Inhaler Devices, Spain, Market Shares by Sales (USD Million), from 2009 to 2010 134
Data table 84: Needle Free Injections, Spain, Market Shares by Sales (USD Million), from 2009 to 2010 135
Data table 85: Drug Delivery Devices March ket Pipeline Products 148
Data table 86: Runfold Medical Takes Over Zimed 152
Data table 87: AorTech International Enters Into Technology License Agreement 153
Data table 88: US Dollar to Local Currency, Europe, Average Exchange Rate from 2003 to 2010 161

1.2

List of Figures


Chart 1: Drug Delivery Devices, Cross Country Comparison, Sales (USD Million), from 2003 to 2017 14
Chart 2: Drug Delivery Devices, Europe, Overall Sales (USD Million), from 2003 to 2017 15
Chart 3: Drug Delivery Devices, Europe, Cross-Category Analysis, from 2003 to 2017 17
Chart 4: Drug Delivery Devices, Europe, Overall Sales (USD Million), Historical data, from 2003 to 2010 18
Chart 5: Drug Delivery Devices, Europe, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 20
Chart 6: Drug Delivery Devices, Europe, Segment Volume (Units), from 2003 to 2017 22
Chart 7: Drug Delivery Devices, Europe, Segment Volume (Units), Historical data, from 2003 to 2010 23
Chart 8: Drug Delivery Devices, Europe, Segment Volume (Units), Forecasted data, from 2010 to 2017 25
Chart 9: Drug Delivery Devices, Europe, Firms share (%), 2010 27
Chart 10: Drug Delivery Devices, Germany, Overall Sales (USD Million), from 2003 to 2017 29
Chart 11: Drug Delivery Devices, Germany, Overall Sales (USD Million), Historical data, from 2003 to 2010 31
Chart 12: Drug Delivery Devices, Germany, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 33
Chart 13: Drug Delivery Devices, Germany, Segment Volume (Units), from 2003 to 2017 35
Chart 14: Drug Delivery Devices, Germany, Segment Volume (Units), Historical data, from 2003 to 2010 36
Chart 15: Drug Delivery Devices, Germany, Segment Volume (Units), Forecasted data, from 2010 to 2017 38
Chart 16: Drug Delivery Devices, Germany, Market Shares (%), 2010 42
Chart 17: Central Venous Catheters, Germany, Market Shares (%), 2010 44
Chart 18: Infusion Systems, Germany, Market Shares (%), 2010 46
Chart 19: Metered Dose Inhaler Devices, Germany, Market Shares (%), 2010 48
Chart 20: Needle Free Injections, Germany, Market Shares (%), 2010 50
Chart 21: Drug Delivery Devices, France, Overall Sales (USD Million), from 2003 to 2017 51
Chart 22: Drug Delivery Devices, France, Overall Sales (USD Million), Historical data, from 2003 to 2010 53
Chart 23: Drug Delivery Devices, France, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 55
Chart 24: Drug Delivery Devices, France, Segment Volume (Units), from 2003 to 2017 57
Chart 25: Drug Delivery Devices, France, Segment Volume (Units), Historical data, from 2003 to 2010 58
Chart 26: Drug Delivery Devices, France, Segment Volume (Units), Forecasted data, from 2010 to 2017 60
Chart 27: Drug Delivery Devices, France, Market Shares (%), 2010 64
Chart 28: Central Venous Catheters, France, Market Shares (%), 2010 66
Chart 29: Infusion Systems, France, Market Shares (%), 2010 68
Chart 30: Metered Dose Inhaler Devices, France, Market Shares (%), 2010 70
Chart 31: Needle Free Injections, France, Market Shares (%), 2010 71
Chart 32: Drug Delivery Devices, United Kingdom, Overall Sales (USD Million), from 2003 to 2017 72
Chart 33: Drug Delivery Devices, United Kingdom, Overall Sales (USD Million), Historical data, from 2003 to 2010 74
Chart 34: Drug Delivery Devices, United Kingdom, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 76
Chart 35: Drug Delivery Devices, United Kingdom, Segment Volume (Units), from 2003 to 2017 78
Chart 36: Drug Delivery Devices, United Kingdom, Segment Volume (Units), Historical data, from 2003 to 2010 79
Chart 37: Drug Delivery Devices, United Kingdom, Segment Volume (Units), Forecasted data, from 2010 to 2017 81
Chart 38: Drug Delivery Devices, United Kingdom, Market Shares (%), 2010 85
Chart 39: Central Venous Catheters, United Kingdom, Market Shares (%), 2010 87
Chart 40: Infusion Systems, United Kingdom, Market Shares (%), 2010 89
Chart 41: Metered Dose Inhaler Devices, United Kingdom, Market Shares (%), 2010 91
Chart 42: Needle Free Injections, United Kingdom, Market Shares (%), 2010 92
Chart 43: Drug Delivery Devices, Italy, Overall Sales (USD Million), from 2003 to 2017 93
Chart 44: Drug Delivery Devices, Italy, Overall Sales (USD Million), Historical data, from 2003 to 2010 95
Chart 45: Drug Delivery Devices, Italy, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 97
Chart 46: Drug Delivery Devices, Italy, Segment Volume (Units), from 2003 to 2017 99
Chart 47: Drug Delivery Devices, Italy, Segment Volume (Units), Historical data, from 2003 to 2010 100
Chart 48: Drug Delivery Devices, Italy, Segment Volume (Units), Forecasted data, from 2010 to 2017 102
Chart 49: Drug Delivery Devices, Italy, Market Shares (%), 2010 106
Chart 50: Central Venous Catheters, Italy, Market Shares (%), 2010 108
Chart 51: Infusion Systems, Italy, Market Shares (%), 2010 110
Chart 52: Metered Dose Inhaler Devices, Italy, Market Shares (%), 2010 112
Chart 53: Needle Free Injections, Italy, Market Shares (%), 2010 114
Chart 54: Drug Delivery Devices, Spain, Overall Sales (USD Million), from 2003 to 2017 115
Chart 55: Drug Delivery Devices, Spain, Overall Sales (USD Million), Historical data, from 2003 to 2010 117
Chart 56: Drug Delivery Devices, Spain, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 119
Chart 57: Drug Delivery Devices, Spain, Segment Volume (Units), from 2003 to 2017 121
Chart 58: Drug Delivery Devices, Spain, Segment Volume (Units), Historical data, from 2003 to 2010 122
Chart 59: Drug Delivery Devices, Spain, Segment Volume (Units), Forecasted data, from 2010 to 2017 124
Chart 60: Drug Delivery Devices, Spain, Market Shares (%), 2010 128
Chart 61: Central Venous Catheters, Spain, Market Shares (%), 2010 130
Chart 62: Infusion Systems, Spain, Market Shares (%), 2010 132
Chart 63: Metered Dose Inhaler Devices, Spain, Market Shares (%), 2010 134
Chart 64: Needle Free Injections, Spain, Market Shares (%), 2010 135
Chart 65: GlaxoSmithKline plc, Market Shares (%),Europe Drug Delivery Devices March ket, 2010 136
Chart 66: Boehringer Ingelheim GmbH, Market Shares (%),Europe Drug Delivery Devices March ket, 2010 137
Chart 67: AstraZeneca PLC, Market Shares (%),Europe Drug Delivery Devices March ket, 2010 138
Chart 68: Sunovion, Market Shares (%),Europe Drug Delivery Devices March ket, 2010 139
Chart 69: Baxter International Inc., Market Shares (%),Europe Drug Delivery Devices March ket, 2010 140
Chart 70: B. Braun Melsungen AG, Market Shares (%),Europe Drug Delivery Devices March ket, 2010 141

Companies Mentioned
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
AstraZeneca PLC
Sunovion
Baxter International Inc.
B. Braun Melsungen AG
CareFusion Corporation
Fresenius Kabi AG
Hospira, Inc.
Medtronic, Inc.
Smiths Medical
Terumo Corporation
Consort Medical plc
3M Health Care
Codman and Shurtleff, Inc.
JMS CO., LTD.
Teleflex Incorporated
Edwards Lifesciences Corporation
Cook Medical Incorporated
INJEX - Equidyne Systems
Bioject Medical Technologies Inc.
Antares Pharma, Inc.

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Pulmonary Drug Delivery Systems: Technologies and Global Markets

Pulmonary Drug Delivery Systems: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • May 2014
  • by BCC Research

Use this report to: - Receive a detailed analysis of the present and future global market for pulmonary drug delivery technologies. - Receive information on pulmonary drug delivery technologies currently ...

RNAi Drug Delivery : Technologies and Gobal Markets

RNAi Drug Delivery : Technologies and Gobal Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This BCC Research report provides an in-depth assessment of recent progress and future opportunities for RNA interference (RNAi) players in major therapeutic and drug delivery areas, including infectious ...

Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • May 2014
  • by Transparency Market Research

nebulizer is a medical device used for the treatment of respiratory disorders (asthma, COPD and cystic fibrosis) that converts liquid medication into mist or aerosol. Thus, the medicine can easily reach ...

Cytotoxic Drug Delivery

May 2014 $ 2 850

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.